“…The following primary antibodies were used to study dopamine-related markers in various brain areas according to protocols established previously (Meyer et al, 2008a;Bitanihirwe et al, 2010a;Vuillermot et al, 2010): rabbit anti-TH (Santa Cruz Biotechnology; diluted 1:500), rabbit antidopamine D 1 receptor (D 1 R) (Millipore Bioscience Research Reagents; diluted 1:250), rabbit anti-dopamine D 2 receptor (D 2 R) (Millipore Bioscience Research Reagents; diluted 1:500), and rabbit anti-catechol-Omethyltransferase (COMT) (SDI; diluted 1:5000). These dopaminergic markers were selected because they are known to be modulated by prenatal immune activation and/or genetic Nurr1 deficiency (Zetterström et al, 1997;Saucedo-Cardenas et al, 1998;Kadkhodaei et al, 2009;Bitanihirwe et al, 2010a;Vuillermot et al, 2010Vuillermot et al, , 2011c and because they are implicated in the dopaminergic neuropathology of schizophrenia and related disorders (Akil et al, 1999;Chen et al, 2004;Howes et al, 2007). All antibodies were diluted in PBS containing 0.3% Triton X-100 and 2% normal serum, and the sections were incubated free-floating overnight at room temperature.…”